SIMILAR PATTERNS OF AMINO ACIDS FOR 6DM0_D_CYZD1302
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wa5 | IMPORTIN ALPHARE-EXPORTER (Saccharomycescerevisiae) |
PF03378(CAS_CSE1)PF03810(IBN_N)PF08506(Cse1) | 5 | GLY C 106LEU C 128LEU C 212ASP C 215LYS C 211 | None | 1.48A | 6dm0A-1wa5C:2.46dm0D-1wa5C:3.4 | 6dm0A-1wa5C:6.016dm0D-1wa5C:6.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ijz | PROBABLE M18-FAMILYAMINOPEPTIDASE 2 (Pseudomonasaeruginosa) |
PF02127(Peptidase_M18) | 5 | PRO A 175GLY A 105SER A 123LEU A 102LEU A 208 | None | 1.42A | 6dm0A-2ijzA:1.36dm0D-2ijzA:undetectable | 6dm0A-2ijzA:11.856dm0D-2ijzA:11.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2n0s | FE-HYDROGENASEFERREDOXIN,CHLOROPLASTIC (Chlamydomonasreinhardtii;Chlamydomonasreinhardtii) |
PF02256(Fe_hyd_SSU)PF02906(Fe_hyd_lg_C)PF00111(Fer2) | 5 | PRO A 378GLY A 383SER B 44LEU B 33ASP B 32 | FES B 101 ( 4.4A)NoneNoneNoneNone | 1.14A | 6dm0A-2n0sA:undetectable6dm0D-2n0sA:undetectable | 6dm0A-2n0sA:9.486dm0D-2n0sA:9.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h6t | GLUTAMATE RECEPTOR 2 (Rattusnorvegicus) |
PF10613(Lig_chan-Glu_bd) | 5 | MET A 107SER A 108LEU A 239LEU A 247LYS A 251 | NoneCYZ A 265 (-2.8A)CYZ A 265 (-4.7A)CYZ A 265 (-4.3A)CYZ A 265 ( 4.4A) | 0.77A | 6dm0A-3h6tA:21.26dm0D-3h6tA:1.4 | 6dm0A-3h6tA:15.446dm0D-3h6tA:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iqd | OCTOPINEDEHYDROGENASE (Pecten maximus) |
PF02317(Octopine_DH) | 5 | PRO B 383GLY B 339LEU B 391LEU B 269ASP B 272 | None | 1.24A | 6dm0A-3iqdB:5.16dm0D-3iqdB:5.0 | 6dm0A-3iqdB:11.286dm0D-3iqdB:11.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p1w | RABGDI PROTEIN (Plasmodiumfalciparum) |
PF00996(GDI) | 5 | PRO A 243GLY A 13SER A 20LEU A 259LEU A 33 | None | 1.48A | 6dm0A-3p1wA:undetectable6dm0D-3p1wA:undetectable | 6dm0A-3p1wA:10.486dm0D-3p1wA:10.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t7b | ACETYLGLUTAMATEKINASE (Yersinia pestis) |
PF00696(AA_kinase) | 5 | GLY A 252LEU A 178LEU A 4ASP A 174LYS A 0 | None | 1.40A | 6dm0A-3t7bA:1.46dm0D-3t7bA:1.8 | 6dm0A-3t7bA:14.866dm0D-3t7bA:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tc8 | LEUCINEAMINOPEPTIDASE (Parabacteroidesdistasonis) |
PF04389(Peptidase_M28) | 5 | PRO A 167SER A 108GLY A 170LEU A 119LEU A 78 | None | 1.38A | 6dm0A-3tc8A:1.96dm0D-3tc8A:1.8 | 6dm0A-3tc8A:13.826dm0D-3tc8A:13.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3um6 | BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE (Plasmodiumfalciparum) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | PRO A 47GLY A 39SER A 189LEU A 221ASP A 222 | None | 1.35A | 6dm0A-3um6A:2.26dm0D-3um6A:3.2 | 6dm0A-3um6A:9.966dm0D-3um6A:9.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fuu | LEUCINEAMINOPEPTIDASE (Bacteroidesthetaiotaomicron) |
PF04389(Peptidase_M28) | 5 | PRO A 169SER A 110GLY A 172LEU A 121LEU A 80 | None | 1.24A | 6dm0A-4fuuA:1.76dm0D-4fuuA:1.4 | 6dm0A-4fuuA:14.446dm0D-4fuuA:14.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g8k | 2-5A-DEPENDENTRIBONUCLEASE (Homo sapiens) |
PF12796(Ank_2)PF13857(Ank_5) | 5 | GLY A 273LEU A 279LEU A 304ASP A 303LYS A 326 | None | 1.09A | 6dm0A-4g8kA:undetectable6dm0D-4g8kA:undetectable | 6dm0A-4g8kA:11.426dm0D-4g8kA:11.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jat | ALPHA-PYRONESYNTHESIS POLYKETIDESYNTHASE-LIKE PKS11 (Mycobacteriumtuberculosis) |
PF00195(Chal_sti_synt_N)PF02797(Chal_sti_synt_C) | 5 | PRO A 341GLY A 229SER A 312LEU A 245LEU A 187 | PLM A 400 ( 4.5A)NonePLM A 400 (-2.5A)NoneNone | 1.49A | 6dm0A-4jatA:undetectable6dm0D-4jatA:undetectable | 6dm0A-4jatA:11.016dm0D-4jatA:11.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ln9 | RIFAMYCIN POLYKETIDESYNTHASE (Amycolatopsismediterranei) |
PF14765(PS-DH) | 5 | PRO A 91GLY A 95SER A 43LEU A 88LEU A 20 | None | 1.49A | 6dm0A-4ln9A:undetectable6dm0D-4ln9A:undetectable | 6dm0A-4ln9A:12.316dm0D-4ln9A:12.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gqr | LEUCINE-RICH REPEATRECEPTOR-LIKEPROTEIN KINASE TDR (Arabidopsisthaliana) |
PF00560(LRR_1)PF08263(LRRNT_2)PF13855(LRR_8) | 5 | PRO B 362GLY B 342SER B 388LEU B 350LEU B 395 | None | 1.22A | 6dm0A-5gqrB:undetectable6dm0D-5gqrB:undetectable | 6dm0A-5gqrB:8.326dm0D-5gqrB:8.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l1b | GLUTAMATE RECEPTOR2,GLUTAMATE RECEPTOR2 (Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | MET A 496LEU A 751LEU A 759ASP A 760LYS A 763 | None | 0.80A | 6dm0A-5l1bA:42.96dm0D-5l1bA:40.1 | 6dm0A-5l1bA:100.006dm0D-5l1bA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l1b | GLUTAMATE RECEPTOR2,GLUTAMATE RECEPTOR2 (Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | MET A 496SER A 497LEU A 751LEU A 759LYS A 763 | None | 0.78A | 6dm0A-5l1bA:42.96dm0D-5l1bA:40.1 | 6dm0A-5l1bA:100.006dm0D-5l1bA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5wel | CHIMERA OF GLUTAMATERECEPTOR 2, GERMCELL-SPECIFIC GENE1-LIKE PROTEIN (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF07803(GSG-1)PF10613(Lig_chan-Glu_bd) | 6 | MET A 496SER A 497LEU A 751LEU A 759ASP A 760LYS A 763 | None | 0.80A | 6dm0A-5welA:43.26dm0D-5welA:53.0 | 6dm0A-5welA:100.006dm0D-5welA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5weo | GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA (Mus musculus;Rattusnorvegicus) |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 6 | MET A 496SER A 497LEU A 751LEU A 759ASP A 760LYS A 763 | CYZ A1302 (-4.3A)CYZ A1302 (-3.2A)NoneNoneCYZ A1302 (-3.8A)CYZ A1302 (-2.9A) | 0.47A | 6dm0A-5weoA:45.46dm0D-5weoA:56.0 | 6dm0A-5weoA:100.006dm0D-5weoA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f4e | CATALYTIC DOMAIN OFBOTULINUM NEUROTOXINX (Clostridiumbotulinum) |
no annotation | 5 | PRO A 174GLY A 180SER A 132LEU A 297LEU A 129 | None | 1.32A | 6dm0A-6f4eA:0.76dm0D-6f4eA:0.5 | 6dm0A-6f4eA:17.056dm0D-6f4eA:17.05 |